HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Paul Van Schil Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Pauwels, M. Articles by Eyskens, E. Search for Related Content PubMed PubMed Citation Articles by Pauwels, M. Articles by Eyskens, E.

Eur J Cardiothorac Surg 1999;14:271-273
© 1999 Elsevier Science NL

Repeat mediastinoscopy in the staging of lung cancer

^a Department of Surgery, Antwerp University Hospital, Wilrijkstraat 10, 2650 Edegem, Belgium
^b Department of Pneumology, Antwerp University Hospital, Wilrijkstraat 10, 2650 Edegem, Belgium

Received 16 February 1998; received in revised form 7 May 1998; accepted 3 June 1998.

Corresponding author. Fax: +32 3 8251308; e-mail: paul.van.schil @ uza.uia.ac.be

Objective: Despite technical difficulties due to mediastinal fibrosis, repeat mediastinoscopy can be a valuable tool in the restaging of lung cancer. It provides essential pathological information on mediastinal invasion when selecting patients for surgical resection after induction chemotherapy in stage IIIa disease. The aim of our study was to evaluate the feasibility, sensitivity and accuracy of repeat mediastinoscopy. Methods: From 1994 to 1997 we performed a repeat mediastinoscopy in 15 patients (13 men, two women) with bronchogenic carcinoma. Their age ranged from 49 to 75 years. (mean 64.7). Seven patients had induction chemotherapy for a non-small cell bronchogenic carcinoma with positive N2 nodes on mediastinoscopy. Four patients had a second primary contralateral lung cancer, one had a locoregional recurrence of bronchogenic carcinoma. The other three had a first mediastinoscopy for other reasons than lung cancer, repeat mediastinoscopy being performed for staging of malignant disease. Results: In all 15 patients it was possible to perform a complete repeat mediastinoscopy. In one patient repeat mediastinoscopy turned out to be false negative, so, in our series, sensitivity was 87.5%, specificity 100% and accuracy 93.7%. Conclusion: Previous mediastinoscopy is no contraindication for a repeat one. Repeat mediastinoscopy offers valuable pathological information in restaging of lung cancer.

Key Words: Mediastinoscopy • Lung cancer • Staging

This article has been cited by other articles:

				C. C.M. Pitz, K. W. Maas, H. A. V. Swieten, A. Brutel de la Riviere, P. Hofman, and F. M.N.H. Schramel Surgery as part of combined modality treatment in stage IIIB non-small cell lung cancer Ann. Thorac. Surg., July 1, 2002; 74(1): 164 - 169. [Abstract] [Full Text] [PDF]

				T. Akhurst, R. J. Downey, M. S. Ginsberg, M. Gonen, M. Bains, R. Korst, R. J. Ginsberg, V. W. Rusch, and S. M. Larson An initial experience with FDG-PET in the imaging of residual disease after induction therapy for lung cancer Ann. Thorac. Surg., January 1, 2002; 73(1): 259 - 266. [Abstract] [Full Text] [PDF]

				M. Mateu-Navarro, R. Rami-Porta, R. Bastus-Piulats, L. Cirera-Nogueras, and G. Gonzalez-Pont Remediastinoscopy after induction chemotherapy in non-small cell lung cancer Ann. Thorac. Surg., August 1, 2000; 70(2): 391 - 395. [Abstract] [Full Text] [PDF]